Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11661456 Sialylated glycoproteins

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 May, 2023
Edits made to:
Infobox (+35 properties)
Article (+195 characters)
‌

 US Patent 11661456 Sialylated glycoproteins

Article

Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Momenta Pharmaceuticals
Momenta Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116614560
Date of Patent
May 30, 2023
0
Patent Application Number
159852880
Date Filed
May 21, 2018
0
Patent Citations
‌
US Patent 11098079 Charged depth filtration of antigen-binding proteins
0
‌
US Patent 7118675 Process for removing protein aggregates and virus from a protein solution
0
‌
US Patent 7138120 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
0
‌
US Patent 7364736 Antibodies to OPGL
0
‌
US Patent 7465397 Process for removing protein aggregates and virus from a protein solution
0
‌
US Patent 7473680 Remodeling and glycoconjugation of peptides
0
‌
US Patent 7655233 Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
0
‌
US Patent 7846431 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
0
‌
US Patent 7871607 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
0
‌
US Patent 8034906 Crystalline anti-hTNFalpha antibodies
0
‌
US Patent 8105586 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
0
‌
US Patent 8187855 Large-scale production of soluble hyaluronidase
0
‌
US Patent 8278072 Method for synthesis of sialylated products using reversible sialylation
0
‌
US Patent 8632773 Antibody composition with altered Fab sialylation
0
‌
US Patent 9217168 Methods of cell culture
0
‌
US Patent 9481902 Quantitative control of sialylation and specific mono-sialylation
0
‌
US Patent 9725501 Two-stage ultrafiltration/diafiltration
0
‌
US Patent 9809835 Quantitative control of sialylation
0
‌
US Patent 9890410 N-acetylhexosamine-containing N-glycans in glycoprotein products
0
‌
US Patent 10087236 Methods for modifying human antibodies by glycan engineering
0
‌
US Patent 10125189 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
0
‌
US Patent 10287315 Method for purifying immunoglobulin
0
‌
US Patent 10344063 Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
0
‌
US Patent 10464996 Methods for the treatment of neurodegeneration
0
‌
US Patent 10668411 Depth filtration media with multiple organic and/or inorganic materials
0
‌
US Patent 10836805 Chemoenzymatic glycoengineering of antibodies and FC fragments thereof
0
‌
US Patent 11377485 Methods for modifying human antibodies by glycan engineering
0
Patent Primary Examiner
‌
Thea D'Ambrosio
0

Find more entities like US Patent 11661456 Sialylated glycoproteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.